Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes
Tumor necrosis factor-α (TNF-α) inhibitors are the main types of biological conventional synthetic disease-modifying antirheumatic drugs and have efficacy in treating ankylosing spondylitis (AS) which is not sensitive for nonsteroidal anti-inflammatory drug. However, the impact of TNF-α inhibitors o...
Saved in:
Main Authors: | Rongjuan Chen, Hongyan Qian, Xiaoqing Yuan, Shiju Chen, Yuan Liu, Bin Wang, Guixiu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2021/1017938 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TNF-α Induced the Enhanced Apoptosis of Mesenchymal Stem Cells in Ankylosing Spondylitis by Overexpressing TRAIL-R2
by: Zhenhua Liu, et al.
Published: (2017-01-01) -
Anti-Osteoporosis Is Imperative in Prevention of Progress of Ankylosing Spondylitis
by: Zheng B, et al.
Published: (2025-01-01) -
Renal function in Ankylosing Spondylitis
by: Renu Saigal, et al.
Published: (2017-01-01) -
PLCG2 and IFNAR1: The Potential Biomarkers Mediated by Immune Infiltration and Osteoclast Differentiation of Ankylosing Spondylitis in the Peripheral Blood
by: Bo Han, et al.
Published: (2024-01-01) -
Coexistence of Ankylosing Spondylitis and Klinefelter's Syndrome
by: Şenol Kobak, et al.
Published: (2013-01-01)